GLP1R and metabolic dysfunction-associated steatotic liver disease: First, a NAFLD mice model showed intragastric butyrate supplementation impeded HFD‐induced hepatic GLP‐1 receptor downregulation, which was independently associated with improved hepatic steatosis.207